Current Report Filing (8-k)
November 14 2022 - 05:00PM
Edgar (US Regulatory)
false000076418000007641802022-10-262022-10-260000764180mo:CommonStock0.3313ParValueMember2022-10-262022-10-260000764180mo:CommonStock1.000NotesDue2023Member2022-10-262022-10-260000764180mo:CommonStock1.700NotesDue2025Member2022-10-262022-10-260000764180mo:CommonStock2.200NotesDue2027Member2022-10-262022-10-260000764180mo:CommonStock3.125NotesDue2031Member2022-10-262022-10-26
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________________________________________________________
FORM 8-K
________________________________________________________________________________________________________________
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 26,
2022
________________________________________________________________________________________________________________
ALTRIA GROUP, INC.
(Exact name of registrant as specified in its charter)
______________________________________________________________________________________________________________
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Virginia |
|
1-08940 |
|
13-3260245 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer
Identification No.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6601 West Broad Street, |
Richmond, |
Virginia |
23230 |
(Address of principal executive
offices) |
|
|
(Zip Code) |
Registrant’s telephone number, including area code:
(804) 274-2200
_______________________________________________________________________________________________________________
(Former name or former address, if changed since last
report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
|
|
|
|
|
☐ |
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
|
|
|
|
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12) |
|
|
|
|
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
Title
of each
class
|
Trading Symbols |
Name of each exchange on which registered |
Common Stock, $0.33 1/3 par value
|
MO |
New York Stock Exchange |
1.000% Notes due 2023
|
MO23A |
New York Stock Exchange |
1.700% Notes due 2025
|
MO25 |
New York Stock Exchange |
2.200% Notes due 2027
|
MO27 |
New York Stock Exchange |
3.125% Notes due 2031
|
MO31 |
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
|
|
|
|
|
|
Emerging growth company
|
☐ |
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
o
Item 8.01. Other
Events.
On October 26, 2022, the United States District Court for the
Eastern District of Virginia (the “Court”) entered an order
granting preliminary approval of the settlement of the shareholder
derivative action captioned
In re Altria Group, Inc. Derivative Litigation,
Case No. 3:20-cv-00772-DJN (the “Federal Action”). The complaint in
the Federal Action, as well as other related shareholder derivative
actions pending in Virginia state courts (collectively with the
Federal Action, the “Actions”), alleges various claims, including
breach of fiduciary duty claims, against certain Altria Group, Inc.
(“Altria”) current and former directors and officers relating to
Altria’s investment in JUUL Labs, Inc. (“JLI”). The complaints in
the Actions also allege various claims against JLI, its founders
and some of its current and former executives. The Actions were
resolved pursuant to an Amended Stipulation and Agreement of
Settlement (the “Stipulation”), a copy of which is attached as
Exhibit 99.1.
Pursuant to the Court’s order granting preliminary approval of the
settlement, Altria is filing the Stipulation and the Notice of
Pendency and Proposed Settlement of Derivative Actions (the
“Notice”), a copy of which is attached as Exhibit 99.2, with the
U.S. Securities and Exchange Commission, publishing a summary of
the Notice in The Wall Street Journal and publishing the
Stipulation and the Notice in the investors section of Altria’s
website at www.altria.com/shareholdersettlement.
Item 9.01. Financial
Statements and Exhibits.
|
|
|
|
|
|
|
|
|
|
|
|
(d) |
Exhibits |
|
|
|
|
|
|
99.1 |
|
|
|
99.2 |
|
|
|
104 |
|
The cover page from this Current Report on Form 8-K, formatted in
Inline XBRL (included as Exhibit 101) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
|
|
|
|
|
|
|
|
ALTRIA GROUP, INC.
|
|
|
|
|
By: |
/s/ W. HILDEBRANDT SURGNER, JR. |
|
Name: |
W. Hildebrandt Surgner, Jr. |
|
Title: |
Vice President, Corporate Secretary and |
|
|
Associate General Counsel |
DATE: November 14, 2022
Altria (NYSE:MO)
Historical Stock Chart
From Feb 2023 to Mar 2023
Altria (NYSE:MO)
Historical Stock Chart
From Mar 2022 to Mar 2023